CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naïve patients with chronic hepatitis B infection
Won Gil Chung, Hong Joo Kim, Young Gil Choe, Hyo Sun Seok, Chang Wook Chon, Yong Kyun Cho, Byung Ik Kim, Young Yool Koh
Clin Mol Hepatol. 2012;18(2):195-202.   Published online 2012 June 26    DOI: https://doi.org/10.3350/cmh.2012.18.2.195

Excel Download

Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naïve patients with chronic hepatitis B infection
Won Gil Chung, Hong Joo Kim, Young Gil Choe, Hyo Sun Seok, Chang Wook Chon, Yong Kyun Cho, Byung Ik Kim, Young Yool Koh
Clinical and Molecular Hepatology. 2012;18(2):195   Crossref logo
Link1 Link2 Link3
Corrections: Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response
Hepatology. 2011;54(6):2281-2282   Crossref logo
Link1 Link2
Entecavir for the treatment of chronic hepatitis B virus infection
S. James Matthews
Clinical Therapeutics. 2006;28(2):184-203   Crossref logo
Link1 Link2
Three Years of Continuous Entecavir Therapy in Treatment-Naïve Chronic Hepatitis B Patients: VIRAL Suppression, Viral Resistance, and Clinical Safety
Man-Fung Yuen, Wai-Kay Seto, James Fung, Danny Ka-Ho Wong, John Chi-Hang Yuen, Ching-Lung Lai
American Journal of Gastroenterology. 2011;106(7):1264-1271   Crossref logo
Link1 Link2 Link3 Link4
Partial Response to Entecavir and Tenofovir in Naïve Patients with Chronic Hepatitis B: Clinical Relevance and Management
Pietro Lampertico, Mauro Viganò, Massimo Colombo
Current Hepatitis Reports. 2012;11(2):90-94   Crossref logo
Link1 Link2 Link3
Comparison between clevudine and entecavir treatment for antiviral-naïve patients with chronic hepatitis B
Hong Joo Kim, Dong Il Park, Jung Ho Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim
Liver International. 2009;30(6):834-840   Crossref logo
Link1 Link2
Efficacy of prolonged entecavir monotherapy in treatment-naïve chronic hepatitis B patients exhibiting a partial virologic response to entecavir
Han Na Choi, Jeong Eun Song, Hyeon Chul Lee, Hyeong Ho Jo, Chang Hyeong Lee, Byung Seok Kim
Clinical and Molecular Hepatology. 2015;21(1):24   Crossref logo
Link1 Link2 Link3
Clinical utility of entecavir for chronic hepatitis B in Chinese patients
Ji-yao Wang
Drug Design, Development and Therapy. 2013;13   Crossref logo
Link1
Su1414 A Randomized Controlled Trial to Compare the Efficacy and Safety of Entecavir Versus Tenofovir Treatment in Naïve Chronic Hepatitis B Patients
Tassanee Sriprayoon
Gastroenterology. 2015;148(4):S-502   Crossref logo
Link1 Link2
Clinical usefulness of noninvasive fibrosis indices for predicting hepatocellular carcinoma in treatment‐naïve patients with chronic hepatitis B following entecavir therapy
Joonho Jeong, Jung Woo Shin, Seok Won Jung, Seung Bum Lee, Eun Ji Park, Neung Hwa Park
Hepatology Research. 2021;51(9):923-932   Crossref logo
Link1 Link2 Link3
This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.